2013 Catecholamines Gordon Research Conference and Gordon Research Seminar

描述（由申请人提供）：2013年关于儿茶酚胺的GRC/GRS研讨会将在佛蒙特州西多佛的雪山度假村举行。2013年8月10日至16日。该会议每隔一年举行一次;它是探索儿茶酚胺领域新发展的理想论坛。这也是初级调查员和受训人员在轻松的气氛中与资深调查员互动的绝佳机会。对最近会议的评价突出表明，这次会议通常对新兴科学家和老牌科学家产生强烈影响。由于戈登会议组织分配的资金有限，我们正在请求其他来源提供资金。我们希望，我们的请求的结果使我们能够支持发言者和讨论领导人以及大量初级调查员参加会议。会议包括两个全体会议，由罗伊·怀斯博士和苏珊·塞萨克博士。初步方案包括大量的初级科学家和妇女，计划的会议包括：1）儿茶酚胺和应激，2）儿茶酚胺和神经障碍，3）物质滥用中的儿茶酚胺，4）儿茶酚胺能传递的突触调节，5）儿茶酚胺受体，6）儿茶酚胺功能的回路水平调节，7）经济决策，8）儿茶酚胺和认知和9）儿茶酚胺转运蛋白。2013年戈登会议上所涉及的主题与理解药物成瘾的神经生物学基础以及各种神经和神经精神障碍（包括精神分裂症、情感障碍、双相情感障碍、强迫症和帕金森病）高度相关。本次论坛将提供一个独特的机会，讨论在了解如何儿茶酚胺系统可能有助于这些条件的病理生理学和治疗的最新进展。事实上，很大一部分参与者是初级研究人员，而且相当多的参与者将是研究生和博士后，这确保这次会议可能会对子孙后代神经科学家如何看待这些问题产生影响。

DESCRIPTION (provided by applicant): The 2013 GRC/GRS Seminar on Catecholamines will take place at Mount Snow Resort, in West Dover, Vermont. August 10 - 16, 2013. This conference is held every other year; it is an ideal forum for exploring new developments in the field of catecholamines. It is also an excellent opportunity for junior investigators and trainees o interact with established investigators in a relaxed atmosphere. The evaluations of recent conferences highlight the strong impact this meeting typically has on emerging as well as established scientists. As the funds allocated by the Gordon Conference organization are limited, we are requesting funding from other sources. We are hoping that the results of our requests enable us to support speakers and discussion leaders as well as a large number of junior investigators to participate in the meeting. The conference includes two plenary talks, by Dr. Roy Wise and Dr. Susan Sesack. The preliminary program includes a large number of junior scientists and women, and the sessions planned include: 1) Catecholamines and Stress, 2) Catecholamines and Neurological Disorders, 3) Catecholamines in Substance Abuse, 4) Synaptic Regulation of Catecholaminergic Transmission, 5) Catecholamines Receptors, 6) Circuit-level Regulation of Catecholamine Function, 7) Economic Decision Making, 8) Catecholamines and Cognition and 9) Catecholamines Transporters. The themes covered in the 2013 Gordon Conference on Catecholamines are highly relevant to understanding the neurobiological bases of drug addiction and a variety of neurological and neuropsychiatric disorders including schizophrenia, affective disorders, bipolar disorder, OCD, and Parkinson's disease. This forum will provide a unique opportunity to discuss recent advances in the understanding of how catecholamine systems may contribute to the pathophysiology and treatment of those conditions. The fact that a large proportion of the participants are junior investigators and a significant number will be graduate students and postdocs ensure that this conference may have an impact on how future generations of neuroscientists view these issues.